How AI is Changing Women's Health Monitoring in 2026
Women's health has been historically underfunded, understudied, and underserved by technology. That is changing. In 2026, artificial intelligence is being applied to women's health challenges at a scale and sophistication that would have been unimaginable a decade ago. From predicting symptom patterns to analyzing biomarkers without blood draws, AI is beginning to close the gap between what women experience and what medicine can measure.
The market that was overlooked
estimated annual spending on women's health globally
Source: McKinsey & Company, "The Dawn of the FemTech Revolution," 2024
Despite representing roughly half the global population and controlling the majority of household healthcare decisions, women have historically been underrepresented in clinical research. A 2020 analysis in the Journal of Women's Health found that women were underrepresented in clinical trials for cardiovascular disease, neurology, and several other fields.
The investment landscape has begun shifting. FemTech venture funding has grown from approximately $500 million in 2019 to over $3 billion annually by 2025, according to PitchBook data. But much of this investment has focused on fertility and pregnancy, leaving a significant gap in midlife women's health.
Where AI is making a difference today
1. Symptom prediction and pattern recognition
One of AI's greatest strengths is finding patterns in complex, multi-variable data. Perimenopausal symptoms are exactly this kind of challenge: dozens of potential symptoms, varying in severity and timing, influenced by sleep, stress, diet, and other factors.
AI-powered apps are now able to analyze symptom logs alongside contextual data (sleep patterns, activity levels, weather, menstrual cycle data) to identify correlations that would be impossible to spot manually. Some systems can predict symptom flares days in advance, giving women the ability to prepare and adapt.
2. Non-invasive biomarker analysis
AI is enabling entirely new approaches to biological measurement. Computer vision systems can now analyze facial images, skin characteristics, and other visible features to detect patterns associated with underlying health states. Natural language processing can assess voice biomarkers. Sensor fusion algorithms can combine data from wearable devices to infer physiological states.
For women's hormonal health, these technologies offer a path to continuous, non-invasive monitoring. Rather than relying on periodic blood tests that capture a single moment, AI-powered tools can track subtle changes over time and identify trends that suggest hormonal transitions.
3. Treatment optimization
Hormone therapy (HT) decisions involve complex trade-offs that vary by individual risk factors, symptom severity, timing, and preferences. AI systems are being developed to assist clinicians in personalizing treatment recommendations based on large-scale outcome data.
Research published in Menopause (the journal of NAMS) has explored machine learning models that predict individual response to hormone therapy based on clinical characteristics. While these tools augment rather than replace clinical judgment, they may help address the significant undertreating of menopausal symptoms documented in multiple studies.
4. Clinical decision support
Many primary care providers receive limited training in menopause management. A 2017 survey in Mayo Clinic Proceedings found that only 20% of ob-gyn residency programs provided a formal menopause curriculum. AI-powered clinical decision support tools can help bridge this knowledge gap by providing evidence-based recommendations at the point of care.
of ob-gyn residency programs provide formal menopause training
Source: Christianson MS et al., Mayo Clinic Proceedings, 2013
Why midlife women's health is the biggest underserved market
The numbers tell a clear story:
- 1.1 billion women will be postmenopausal globally by 2030 (WHO). The menopausal transition affects virtually all women who live to midlife.
- 80% experience symptoms during the transition (SWAN Study), yet the majority never receive targeted treatment.
- Average age of perimenopause onset is 44-47, meaning most women spend a decade or more navigating this transition with minimal technological support.
- $26 billion in annual productivity loss is associated with menopausal symptoms in the U.S. alone, according to a 2023 Mayo Clinic study.
This is not a niche market. It is one of the largest addressable health populations in the world, and it has been largely ignored by health technology until recently.
What's coming next
Several trends are likely to shape AI in women's health over the next 2-3 years:
Multimodal health assessment
The most promising AI applications combine multiple data types: visual (facial analysis, skin), acoustic (voice biomarkers), behavioral (sleep, activity), and self-reported (symptoms, mood). These multi-signal approaches are likely to be more robust and accurate than any single-modality tool.
Personalized wellness trajectories
As longitudinal datasets grow, AI systems will increasingly be able to show women where they are in their personal transition journey, not based on population averages but on their own unique pattern of changes over time.
Integration with clinical care
The gap between consumer wellness tools and clinical medicine is narrowing. Expect to see AI-powered monitoring tools that generate structured reports suitable for sharing with healthcare providers, turning subjective experiences into objective data that clinicians can act on.
Preventive health connections
Hormonal health during the menopausal transition is associated with long-term risks for cardiovascular disease, osteoporosis, and cognitive decline. AI systems that connect current hormonal wellness patterns with downstream health implications may help shift the focus from reactive treatment to proactive prevention.
What this means for women today
The technology landscape for women's health is better in 2026 than it has ever been. But it's still early. The most important thing women can do right now is start tracking. The data you collect today about your symptoms, your patterns, and your changes over time becomes increasingly valuable as AI tools improve.
- Start monitoring. Whether through an app, a journal, or a combination, begin capturing what you're experiencing. Longitudinal data is the foundation everything else builds on.
- Explore new tools. Non-invasive monitoring technologies are becoming available now. Try them with realistic expectations: they're wellness tools, not replacements for medical care.
- Share data with your provider. Structured, longitudinal health data is far more useful in a clinical conversation than trying to remember symptoms from the past few months.
- Stay informed. The field is evolving rapidly. What's experimental today may be standard practice within a few years.
AI-powered hormonal wellness monitoring
MARKABLE combines facial biomarker analysis, symptom tracking, and AI pattern recognition to help you understand what's changing. 60 seconds. No needles.
See How It Works → Try Your Free Check →